Current prescribing patterns for hypertension and atherosclerotic cardiovascular disease (ASCVD) in MSF programmes and their association with treatment outcomes and renal function: could there be a role for fixed dose combination drugs?

Principal investigator

Helen Bygrave
Purpose of study
Purpose of study

The purpose of the study is to inform the revision of guidelines for hypertension and ASCVD care in MSF noncommmunicble (NCD) disease projects, to simplify treatment for both patient and prescriber, in order to improve overall medication use (pres...

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline


  • Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluation
    Murphy, Adrianna "–" Springer Science and Business Media LLC "(2022)"
  • Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
    Webster, Ruth "–" Ubiquity Press, Ltd. "(2020)"
  • Addressing Failures in Achieving Hypertension Control in Low- and Middle-Income Settings through Simplified Treatment Algorithms
    Cohn, Jennifer "–" Ubiquity Press, Ltd. "(2022)"
Previous study
Next study